Studies indicate thermoregulatory changes affect roughly 5-10% of GLP-1 users, typically during dose escalation or within the first 4-6 weeks of treatment initiation
Side Effects & Serious Risks Nausea & flushing: Dose-dependent nausea and facial flushing are the most common short-term effects [2]
48 FilomeniG.CirioloM
[DOI] [PMC free article] [PubMed] [Google Scholar] 40.Meissner W.G., Remy P., Giordana C., Maltete D., Derkinderen P., Houeto J.L., Anheim M., Benatru I., Boraud T., Brefel-Courbon C., et al
Mood Changes & Anxiety Mechanism: Estrogen decline reduces serotonin receptor sensitivity, dopamine production, and GABA activity Cellular solution: Magnesium supports neurotransmitter synthesis and receptor function